Showing results (411-420 of 426) with videos related to

Sort By:
Pageof 43
JACC. Advances|December 20, 2025
Dapagliflozin in Acute Cardiovascular Conditions: Insights From the DEFENDER TrialCaio A M Tavares, Luciano C P Azevedo, Patrícia O Guimarães, et al.
Lancet (London, England)|September 2, 2025
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trialsFaiez Zannad, Christopher M O'Connor, Javed Butler, et al.
Trials|October 15, 2013
Routine versus selective cardiac magnetic resonance in non-ischemic heart failure - OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B)Ian Paterson, George A Wells, Justin A Ezekowitz, et al.
Lancet (London, England)|April 10, 2024
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trialsJaved Butler, Sanjiv J Shah, Mark C Petrie, et al.
The Canadian Journal of Cardiology|October 19, 2025
Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%)Sean Virani, Shelley Zieroth, Natasha Aleksova, et al.
The New England Journal of Medicine|August 30, 2011
Apixaban versus warfarin in patients with atrial fibrillationChristopher B Granger, John H Alexander, John J V McMurray, et al.
The Canadian Journal of Cardiology|February 1, 2014
The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: focus on rehabilitation and exercise and surgical coronary revascularization, Gordon W Moe, Justin A Ezekowitz, et al.
The New England Journal of Medicine|April 8, 2024
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 DiabetesMikhail N Kosiborod, Mark C Petrie, Barry A Borlaug, et al.
The Canadian Journal of Cardiology|December 24, 2014
The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implicationsGordon W Moe, Justin A Ezekowitz, Eileen O'Meara, et al.
The Canadian Journal of Cardiology|November 8, 2017
2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart FailureJustin A Ezekowitz, Eileen O'Meara, Michael A McDonald, et al.
Pageof 43